Lee Bor-Shiunn, Lee Chien-Chen, Wang Yi-Ping, Chen Hsiao-Jan, Lai Chern-Hsiung, Hsieh Wan-Ling, Chen Yi-Wen
Graduate Institute of Oral Biology, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.
Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.
Int J Nanomedicine. 2016 Jan 18;11:285-97. doi: 10.2147/IJN.S94270. eCollection 2016.
Chronic periodontitis is characterized by inflammation of periodontal tissues, leading to bone resorption and tooth loss. The goal of treatment is to regenerate periodontal tissues including bone and cementum lost as a consequence of disease. The local delivery of tetracycline was proven to be effective in controlling localized periodontal infection without apparent side effects. Previous studies suggested that lovastatin has a significant role in new bone formation; however, the local delivery of lovastatin might enhance its therapeutic effects. A number of local delivery devices have been developed recently, including poly(D,L-lactide-co-glycolide acid) (PLGA) nanoparticles. The aim of this study was to develop a local delivery device, PLGA-lovastatin-chitosan-tetracycline nanoparticles, which allows the sequential release of tetracycline and lovastatin to effectively control local infection and promote bone regeneration in periodontitis. The size and microstructure of nanoparticles were examined by transmission electron microscopy, Nanoparticle Size Analyzer, and Fourier transform infrared spectroscopy. The release of tetracycline and lovastatin was quantified using a UV-Vis spectrophotometer. Furthermore, the cytotoxic effect and alkaline phosphatase activity of the nanoparticles in osteoblast cell cultures as well as antibacterial activity against periodontal pathogens were investigated. Finally, the bone regeneration potential of PLGA nanoparticles in three-walled defects in beagle dogs was investigated. The results indicated that PLGA-lovastatin-chitosan-tetracycline nanoparticles showed good biocompatibility, antibacterial activity, and increased alkaline phosphatase activity. The volumetric analysis from micro-CT revealed significantly increased new bone formation in defects filled with nanoparticles in dogs. This novel local delivery device might be useful as an adjunctive treatment in periodontal regenerative therapy.
慢性牙周炎的特征是牙周组织炎症,导致骨吸收和牙齿脱落。治疗的目标是使因疾病而丧失的包括骨和牙骨质在内的牙周组织再生。已证明局部递送四环素在控制局限性牙周感染方面有效且无明显副作用。先前的研究表明洛伐他汀在新骨形成中起重要作用;然而,局部递送洛伐他汀可能会增强其治疗效果。最近已开发出多种局部递送装置,包括聚(D,L-丙交酯-共-乙交酯酸)(PLGA)纳米颗粒。本研究的目的是开发一种局部递送装置,即PLGA-洛伐他汀-壳聚糖-四环素纳米颗粒,其可使四环素和洛伐他汀顺序释放,以有效控制局部感染并促进牙周炎中的骨再生。通过透射电子显微镜、纳米颗粒尺寸分析仪和傅里叶变换红外光谱法检查纳米颗粒的大小和微观结构。使用紫外可见分光光度计对四环素和洛伐他汀的释放进行定量。此外,还研究了纳米颗粒在成骨细胞培养物中的细胞毒性作用和碱性磷酸酶活性以及对牙周病原体的抗菌活性。最后,研究了PLGA纳米颗粒在比格犬三壁骨缺损中的骨再生潜力。结果表明,PLGA-洛伐他汀-壳聚糖-四环素纳米颗粒具有良好的生物相容性、抗菌活性并增加了碱性磷酸酶活性。显微CT的体积分析显示,填充有纳米颗粒的犬骨缺损中的新骨形成显著增加。这种新型局部递送装置可能作为牙周再生治疗的辅助治疗手段有用。